BCWM
DVAX

Bartlett & Co Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Bartlett & Co Wealth Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$1.54K – 1303
2025
Q4 		$1.54K Sell
100
-3,000
-97% -$33K ﹤0.01% 1132
2025
Q3 		$30.8K Hold
3,100
– – ﹤0.01% 751
2025
Q2 		$30.8K Hold
3,100
– – ﹤0.01% 741
2025
Q1 		$40.2K Sell
3,100
-150
-5% -$1.99K ﹤0.01% 692
2024
Q4 		$41.5K Sell
3,250
-250
-7% -$3.02K ﹤0.01% 689
2024
Q3 		$39K Hold
3,500
– – ﹤0.01% 703
2024
Q2 		$39.3K Hold
3,500
– – ﹤0.01% 699
2024
Q1 		$43.4K Hold
3,500
– – ﹤0.01% 685
2023
Q4 		$49.8K Buy
+3,500
New +$48.6K ﹤0.01% 706

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bartlett & Co Wealth Management's DVAX Position: Q1 2026 in Review

Bartlett & Co Wealth Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 100 shares — an estimated $1.54K sold.

Bartlett & Co Wealth Management first reported a position in DVAX in Q4 2023 and held it in 9 quarters. The position peaked at $49.8K in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Bartlett & Co Wealth Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 100 Dynavax Technologies shares in Q1 2026, an estimated $1.54K.
  • Bartlett & Co Wealth Management first reported a position in Dynavax Technologies in Q4 2023 and held it in 9 quarters.
  • Bartlett & Co Wealth Management's Dynavax Technologies position peaked at $49.8K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.